
Orakl Oncology is a pioneering precision oncology company founded in 2023 as a spin-off from the Gustave Roussy Institute, focused on accelerating oncology drug development through a first-in-class…

Orakl Oncology is a pioneering precision oncology company founded in 2023 as a spin-off from the Gustave Roussy Institute, focused on accelerating oncology drug development through a first-in-class…
Founded: 2023
Headquarters: Villejuif, Île-de-France, France
Focus: AI-powered precision oncology platform for drug development
Flagship products: O-Predict; O-Validate
Notable funding: Seed round (Dec 2024); ~€11M–€15M total raised
28 employees
Cancer drug development, with an emphasis on colorectal and pancreatic cancers
2023
Biotechnology Research
≈€11,000,000
Seed round announced Dec 3, 2024; reporting cites nondilutive support from Bpifrance and total capital raised to date near €15M in some sources.
“Bpifrance; Singular; additional investors recorded (Amazon Web Services, HCVC, SistaFund, Speedinvest, Verve Ventures)”
Orakl’s operational engine relies on a fast-growing platform that cultures, expands, freezes, and screens hundreds of patient-derived organoids (PDOs). As the Process Optimisation Intern, you will work with our laboratory, operations, and data teams to design and test new strategies that strengthen the robustness, efficiency, and scalability of this platform. Your role is to analyse our current workflows end-to-end and propose actionable improvements that enhance throughput, resource allocation, and cross-team coordination.
You will address practical and strategic questions essential to supporting Orakl’s rapid growth: how to streamline the duplication and expansion of PDOs; how to model the optimal number of lines that must be thawed or expanded at a given time; how to incorporate fresh samples into planning constraints; how to increase weekly screening capacity; and how to maintain high-quality traceability without burdening teams. You will work closely with wet-lab operators, the planning team, and data scientists to design prototypes, test ideas, and translate your findings into operational improvements.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
82,000+
Open Roles
3,800+
New This Week
| Company |
|---|
Technical Interview (45 minutes call) – A deep dive into your technical skills and expertise relevant to the role.
Founder Interview: As final step of our recruitment process, you will meet the founders of Orakl Oncology in person at our office. This meeting is an opportunity for the founders to assess cultural fit and ensure alignment with our company values.